(2)Commission Implementing Regulation (EU) 2020/1511note extended the approval period of the active substances chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, indoxacarb, MCPA, MCPB, and prosulfocarb until 31 October 2021, of the active substance tritosulfuron until 30 November 2021 and of the active substances amidosulfuron, bifenox, clofentezine, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, lenacil, nicosulfuron, paraffin oils, picloram, sulphur and triflusulfuron until 31 December 2021. Commission Implementing Regulation (EU) 2020/2104note extended the approval period of the active substance paraffin oil until 31 December 2021. Commission Implementing Regulation (EU) 2017/555note extended the approval period of the active substances chlormequat, propaquizafop and quizalofop-P-ethyl until 30 November 2021 and of the active substances 2-phenylphenol (including its salts such as the sodium salt), dimethachlor, etofenprox, penconazole, tetraconazole and tri-allate until 31 December 2021. Commission Implementing Regulation (EU) 2017/1530note extended the approval period of the active substance quizalofop-P-tefuryl until 30 November 2021.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.